GT
ACA icon

Glenmede Trust’s Arcosa ACA Stock Holding History

Glenmede Trust’s Portfolio ACA Stock Details ACA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.1M Sell
145,481
-5,982
-4% -$743K 0.09% 180
2026
Q1 		$16.1M Sell
151,463
-14,009
-8% -$1.59M 0.08% 212
2025
Q4 		$17.6M Buy
+165,472
New +$16.7M 0.08% 205
2025
Q1 		$15.1M Sell
196,167
-6,410
-3% -$588K 0.08% 247
2024
Q4 		$19.6M Sell
202,577
-1,297
-0.6% -$130K 0.1% 205
2024
Q3 		$19.3M Sell
203,874
-2,760
-1% -$241K 0.09% 223
2024
Q2 		$17.2M Buy
206,634
+1,167
+0.6% +$97.2K 0.09% 228
2024
Q1 		$17.6M Buy
205,467
+13,931
+7% +$1.13M 0.09% 238
2023
Q4 		$15.8M Sell
191,536
-4,720
-2% -$346K 0.08% 247
2023
Q3 		$14.1M Sell
196,256
-2,108
-1% -$160K 0.08% 251
2023
Q2 		$12.7M Buy
198,364
+388
+0.2% +$26.1K 0.07% 289
2023
Q1 		$12.5M Buy
197,976
+2,147
+1% +$126K 0.07% 290
2022
Q4 		$10.6M Sell
195,829
-24,218
-11% -$1.44M 0.06% 319
2022
Q3 		$12.6M Sell
220,047
-26,557
-11% -$1.47M 0.08% 262
2022
Q2 		$11.4M Sell
246,604
-26,995
-10% -$1.41M 0.07% 322
2022
Q1 		$15.7M Sell
273,599
-2,895
-1% -$149K 0.08% 305
2021
Q4 		$14.6M Sell
276,494
-2,246
-0.8% -$120K 0.07% 322
2021
Q3 		$14M Sell
278,740
-3,502
-1% -$181K 0.07% 303
2021
Q2 		$16.6M Sell
282,242
-790
-0.3% -$48.9K 0.09% 263
2021
Q1 		$18.4M Sell
283,032
-74,427
-21% -$4.57M 0.1% 229
2020
Q4 		$19.6M Sell
357,459
-28,292
-7% -$1.44M 0.11% 224
2020
Q3 		$17M Sell
385,751
-60,384
-14% -$2.65M 0.1% 225
2020
Q2 		$18.8M Sell
446,135
-123,989
-22% -$4.77M 0.12% 214
2020
Q1 		$25.4M Hold
570,124
– – 0.12% 244
2019
Q4 		$25.4M Buy
570,124
+569,878
+231,658% +$21.9M 0.12% 244
2019
Q3 		$8K Sell
246
-420
-63% -$14.5K ﹤0.01% 2430
2019
Q2 		$25K Hold
666
– – ﹤0.01% 1968
2019
Q1 		$20K Hold
666
– – ﹤0.01% 2059
2018
Q4 		$18K Buy
+666
New +$18.3K ﹤0.01% 2033

Other funds holding ACA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Glenmede Trust's ACA Position: Q2 2026 in Review

Glenmede Trust reduced its Arcosa (ACA) stake by 3.9% in Q2 2026, selling an estimated $743K and leaving 145,481 shares worth $21.1M. The position accounts for 0.09% of the portfolio, ranked #180.

Glenmede Trust first reported a position in ACA in Q4 2018 and has held it in 29 quarters since. The position peaked at $25.4M in Q1 2020. 428 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Glenmede Trust held 145,481 shares of Arcosa worth $21.1M as of Q2 2026.
  • Glenmede Trust sold 5,982 Arcosa shares in Q2 2026, an estimated $743K.
  • Arcosa made up 0.09% of Glenmede Trust's portfolio in Q2 2026, its #180 holding.
  • Glenmede Trust first reported a position in Arcosa in Q4 2018 and has held it in 29 quarters since.
  • Glenmede Trust's Arcosa position peaked at $25.4M in Q1 2020.
  • 428 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.